医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial

广告
第一作者: Michael,Friedlander
作者单位: University of New South Wales Clinical School and Department of Medical Oncology, Prince of Wales [1] Department of Medical Oncology, Peter MacCallum Cancer Centre, and the Sir Peter MacCallum [2] Medical Oncology [3] Department of Medical Oncology, Monash Health and Faculty of Medicine, Nursing and Health Sciences [4] Medical Oncology Department,Blacktown Hospital [5] Department of Cancer and Blood,Auckland City Hospital [6] Department of Medical Oncology,Linear Clinical Research and University of Western Australia [7] Department of Medical Oncology,Royal North Shore Hospital [8] Department of Medical Oncology,Mid North Coast Cancer Institute [9] Department of Medical Oncology,Icon Cancer Centre Wesley [10] Department of Medicine/Division of GI Medicine and Early Phase Clinical Trial Program, Roswell Park [11] Department of Medical Oncology,Hospital Clínico Universitario, INCLIVA Biomedical Research [12] Department of Clinical Development, BeiGene (Beijing) Co., Ltd. [13] Department of Biostatistics, BeiGene USA, Inc. [14] Department of Medical Oncology,Virginia Cancer Specialists Research Institute [15]
发布时间 2023-10-24
提交
  • 浏览0
The British journal of cancer

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷